Description

Movalis (meloxicam) tablets 7.5 mg. №20

Ingredients

Active ingredient: Meloxicam 7.5 mg per tablet.

Dosage

Dosage: The usual dose is 7.5 mg once daily. Consult your doctor for the correct dosage based on your condition.

Indications

Indications: Movalis tablets are indicated for the relief of pain and inflammation in osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis.

Contraindications

Contraindications: Do not use Movalis if you have a history of allergic reactions to meloxicam or other NSAIDs, or if you have active peptic ulcers.

Directions

Directions: Take Movalis tablets orally with a full glass of water. Do not crush or chew the tablets.

Scientific Evidence

Meloxicam, the active ingredient in Movalis, is a nonsteroidal anti-inflammatory drug (NSAID) that works by inhibiting the enzyme cyclooxygenase (COX), thereby reducing inflammation and pain. Studies have shown that meloxicam is effective in managing the symptoms of various inflammatory conditions, including arthritis. Research published in the Journal of Clinical Rheumatology demonstrated the efficacy of meloxicam in improving pain, stiffness, and physical function in patients with osteoarthritis.

Additional Information

It is important to follow the prescribed dosage and duration of treatment with Movalis to minimize the risk of side effects. Common side effects may include gastrointestinal discomfort, headache, and dizziness. Inform your doctor of any existing medical conditions or medications before starting Movalis therapy.

Pharmacological Effects: Meloxicam exerts its pharmacological effects by inhibiting prostaglandin synthesis, which plays a crucial role in inflammation and pain. By selectively targeting COX-2 enzymes, meloxicam reduces inflammation while potentially minimizing the gastrointestinal side effects associated with traditional NSAIDs that also inhibit COX-1 enzymes.

Clinical Trials: Clinical trials have demonstrated the efficacy of meloxicam in providing pain relief and improving joint function in patients with arthritis. A study published in the Journal of Rheumatology compared the effectiveness of meloxicam with other NSAIDs and found it to be equally effective in managing arthritis symptoms with a lower risk of gastrointestinal complications.